Sorbie Bornholm

Home
United Kingdom
London
Sorbie Bornholm

Global investment firm that provides funding for ongoing business objectives to listed micro, small and mid-cap growth companies.

24/04/2026

Sorbie Bornholm LP is pleased to share a strong operational and financial update from our ongoing partnership with ARES Strategic Mining Inc.

Through our performance-based Sharing Agreements, Ares continues to generate non-dilutive capital—delivering approximately 118% additional cash in the most recent settlement period. At the same time, the Company is advancing steadily toward production at its Lost Sheep Fluorspar Project, with several thousand tons of ore stockpiled at surface and underground operations continuing to build inventory.

As the only permitted fluorspar mine in the United States, Ares is uniquely positioned within a tightening global supply environment for this critical mineral.

We remain focused on disciplined capital deployment and long-term value creation.

02/04/2026

The 24 hour era of Sorbie Blondholm has officially come to a close. Sorbie Bornholm is back.

Same Sharing Agreement. Same mission. Same team. Still very blond.

Happy April Fools!

01/04/2026

Sorbie Bornholm is pleased to announce that, after months of careful deliberation, we have officially rebranded.

Introducing Sorbie Blondholm.

The decision, frankly, was long overdue. When your team is this golden, the name should reflect it. Our Sharing Agreement, our commitment to micro, small, and mid-cap growth companies, and our 25-year track record of responsible shareholding remains unchanged.

The highlights, however, are very much intentional.

Delivering non-dilutive additional capital solutions for growth-stage companies while looking like this?

What, like it's hard?

Name a better rebrand. We'll wait. 💁🏼‍♀️

27/03/2026

Big news: Cynthia Pussinen has joined Sorbie Bornholm as Managing Director, Biotech Investments.

And who better to lead our biotech expansion than someone who’s lived the fundraising hustle from the inside? Cynthia understands what management teams need from a capital partner to achieve success, because she’s been there herself.

Cynthia brings 30+ years of experience across global pharmaceutical and emerging biotech, half of which has been in C-suite roles (CEO, President, COO, and CTO). Her track record speaks for itself:

🧬Built and led global drug discovery and development organizations.
🤝Forged strategic partnerships with the world's leading pharma companies.
🧪 Led teams responsible for delivering 15 new medical therapies to patients worldwide.

At Sorbie, Cynthia will focus on identifying promising public biotech companies that are advancing novel therapeutics that just need the right capital to hit their next major milestone. We’re here to bridge that gap and accelerate innovation.

Biotech Issuers: If you’re looking for a supportive, long-term capital partner who actually understands your science and your struggle, look no further.

Cynthia, we can't wait to walk this path with you. Welcome to the team!

26/03/2026

Sorbie Bornholm is pleased to announce a CAD$6,000,000 investment in Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) and the initiation of a new Sharing Agreement.

The investment will support the continued advancement of the company’s Accum® intracellular drug-delivery platform, which is being developed to enhance the effectiveness of antibody-drug conjugates, vaccines, and other biologics.

Defence Therapeutics continues to advance development across oncology and next-generation biologics as demand grows for technologies that improve the delivery and efficacy of targeted therapies.

Sorbie looks forward to supporting the company as it continues to develop its platform and expand its research and development initiatives.

$DTC

24/03/2026

Sorbie Bornholm LP is pleased to report another strong settlement period with Ares Strategic Mining Inc..

During the most recent period, the Company generated 153% additional cash under Sharing Agreement 2 and 94% additional cash under Sharing Agreement 1, demonstrating the continued performance of the Sorbie Sharing Agreement structure.

This non-dilutive capital supports Ares’ continued operational progress at the Lost Sheep Fluorspar Project in Utah, where underground mining is active and several thousand tons of ore have already been stockpiled at surface ahead of processing.

With Lost Sheep positioned to become the only domestic source of fluorspar in the United States, we are pleased to support Ares as it advances toward production.

19/03/2026

Sorbie Bornholm is pleased to announce a CAD$1,950,000 investment in Replenish Nutrients Holding Corp. (CSE: ERTH) and the initiation of a new Sharing Agreement.

The investment will support the continued growth of Replenish Nutrients ERTH, including expanding production capacity, strengthening distribution channels, and advancing the commercialization of its regenerative fertilizer solutions across North America.

Replenish Nutrients is focused on improving soil health and helping farmers adopt more sustainable agricultural practices as demand for regenerative farming solutions continues to grow.

Sorbie looks forward to supporting the company as it continues scaling operations and expanding its presence in the agricultural inputs sector.

Address

9th Floor, 107 Cheapside
London

Telephone

+442030971800

Website

http://www.sorbiebornholm.co.uk/

Alerts

Be the first to know and let us send you an email when Sorbie Bornholm posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Sorbie Bornholm:

Shortcuts

Want your business to be the top-listed Finance Company in London?